ContraFect Corp. | Cash Flow


No data

About ContraFect

View Profile
Address
28 Wells Avenue
Yonkers New York 10701
United States
Employees -
Website http://www.contrafect.com
Updated 07/08/2019
ContraFect Corp. engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.